Skip to the answer

Bupivacaine Uses, Dosage, Side Effects and Interactions

Brand names
Marcaine

Marcaine was approved by the FDA in May 1984 as an injection. An FDA-approved generic with the same active ingredient is listed.

Sensorcaine

Sensorcaine is a bupivacaine brand from before 1982 that comes as an injection. An FDA-approved generic with the same active ingredient is listed.

Xaracoll

Xaracoll was approved by the FDA in August 2020 as an implant. The FDA now lists it as discontinued; generic bupivacaine is still listed.

Posimir

Posimir was approved by the FDA in February 2021 as an injection. The FDA now lists it as discontinued; generic bupivacaine is still listed.

Sensorcaine MPF

Sensorcaine MPF is a brand of bupivacaine that comes as an injection. An FDA-approved generic with the same active ingredient is listed.

Bupivacaine Spinal

Bupivacaine Spinal is a brand name for bupivacaine. Generic bupivacaine is listed with the FDA.

Marcaine Spinal

Marcaine Spinal is a brand of bupivacaine that comes as an injection. An FDA-approved generic with the same active ingredient is listed.

Bupivacaine is a long-acting numbing medicine (local anesthetic) given by injection to block pain during surgery, dental and oral procedures, childbirth, and diagnostic procedures, and to ease pain after surgery.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 19, 2026 Where our facts come from

Quick links

Ask Anything About BupivacaineType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Bupivacaine in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Bupivacaine (Marcaine, Sensorcaine) is a long-acting local anesthetic, a numbing injection that blocks pain signals along nerves. It is a standard choice for surgery, dental work and childbirth when numbness must last for hours, has been on the U.S. market since about 1972, and FDA-approved generics are listed. Most people tolerate it well, and the side effects people notice are nausea, dizziness or a dip in blood pressure. Its boxed warning reports cardiac arrest, sometimes fatal and very hard to reverse, mostly when the strongest concentration was used for epidurals in childbirth, so that strength is not recommended there.

Key Takeaways From the HelloPharmacist Team

  • Speak up right away if you notice tingling around the lips, a metallic taste, ringing ears or sudden restlessness after the injection.
  • Before the procedure, tell your team about liver or kidney disease, heart problems, pregnancy, and any past reaction to a numbing injection.
  • Expect numbness to last for hours, so protect the numb area from bumps, hot drinks and accidental biting until feeling returns.
  • Bring a full medicine list, because MAO inhibitors, tricyclic antidepressants and nonselective beta-blockers can push blood pressure dangerously high with the epinephrine version.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Bupivacaine.

The stronger 0.75% (7.5 mg/mL) concentration is not recommended for epidural anesthesia in childbirth. Cardiac arrest, sometimes fatal and very hard to treat, has been reported in obstetric patients, mostly with this strength. It has followed seizures from the drug reaching the bloodstream by accident. This strength is meant for surgeries needing strong muscle relaxation and long effect.

Read the full warning on DailyMed →

Bupivacaine by the Numbers

Strengths
7
in one form
Makers and packagers
24
Earliest FDA record
1972
Rank by Medicaid prescriptions
#424 of 1,682 drugs
More prescriptions than 74% of the 1,682 drugs we measure
166,102 prescriptions, Q1–Q4 2025

Patient Information Guide for Bupivacaine

What It’s Used For

Bupivacaine is a local anesthetic used for numbing and pain relief. Uses depend on the product:

  • Bupivacaine Hydrochloride injection (including Marcaine): local or regional anesthesia or analgesia in adults for surgery, dental and oral surgery, diagnostic and therapeutic procedures, and obstetrical procedures.
  • Bupivacaine Spinal (7.5 mg/mL): spinal anesthesia (subarachnoid block) in adults.
  • Exparel: pain relief after surgery by infiltration (ages 6 and older), or by interscalene brachial plexus, popliteal sciatic, or adductor canal nerve block in adults.
  • Xaracoll: placed in the surgical site for up to 24 hours of pain relief after open inguinal hernia repair in adults.

How It Works

Bupivacaine blocks the start and travel of nerve impulses, probably by making nerves harder to excite and slowing the signal. Pain signals are stopped first, then temperature, touch, position sense, and muscle tone. Epinephrine, when added, narrows blood vessels so the drug is absorbed more slowly and works longer.

Drug Class

Drug Class

  • Amide Local Anesthetic
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Amide Local Anesthetic

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)

None listed for Bupivacaine in the FDA’s index.

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)
  • Local Anesthesia

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Amides

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Amides

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Bupivacaine is injected by a trained professional, so there are no missed doses or food rules for you. The dose and strength depend on the procedure, the area numbed, and your health.

The lowest effective dose is used.

  • Routes include infiltration, nerve block, epidural, caudal, spinal, and retrobulbar, depending on the product.
  • It is not for intrathecal use unless the product is a spinal-specific one.
  • Large volumes are not injected quickly. Smaller incremental doses are used when possible.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Bupivacaine Injection

Numbing for surgery and procedures
Adults · Local infiltration Highest dose 400 mg in 24 hours

Step by step

  1. Up to 70 mL (without epinephrine)
  2. Up to 175 mg (without epinephrine)

Good to know

Doses may be repeated once every three hours

Adults · 400 mg (1) Highest dose 400 mg in 24 hours

Step by step

  1. 5-35 mL (without epinephrine)
  2. 25-175 mg (without epinephrine)
  3. Moderate to complete motor block

Good to know

Doses may be repeated once every three hours

Adults · 400 mg (2) Highest dose 400 mg in 24 hours

Step by step

  1. 5-70 mL (without epinephrine)
  2. 12.5-175 mg (without epinephrine)
  3. Moderate to complete motor block

Good to know

Doses may be repeated once every three hours

Adults · Retrobulbar Highest dose 400 mg in 24 hours

Step by step

  1. 2-4 mL
  2. 15-30 mg
  3. Complete motor block
Adults · Sympathetic Highest dose 400 mg in 24 hours

Step by step

  1. 20-50 mL
  2. 50-125 mg
Adults · 400 mg (3) Highest dose 400 mg in 24 hours

Step by step

  1. 15-30 mL
  2. 75-150 mg
  3. Moderate to complete motor block
Adults · 400 mg (4) Highest dose 400 mg in 24 hours

Step by step

  1. 15-30 mL
  2. 37.5-75 mg
  3. Moderate motor block
Adults · 400 mg (5) Highest dose 400 mg in 24 hours

Step by step

  1. 10-20 mL
  2. 75-150 mg
  3. Complete motor block

Good to know

Not for obstetrical anesthesia

Adults · 400 mg (6) Highest dose 400 mg in 24 hours

Step by step

  1. 10-20 mL
  2. 50-100 mg
  3. Moderate to complete motor block
Adults · 400 mg (7) Highest dose 400 mg in 24 hours

Step by step

  1. 10-20 mL
  2. 25-50 mg
  3. Partial to moderate motor block

See the Full Dosing Instructions on DailyMed →

Bupivacaine 7.5 mg/mL Injection

Spinal anesthesia for surgery and delivery
Adults · Starting dose Starting dose 6 mg
  • Starting dose, 6 mg (0.8 mL)
Adults · Extremity perineal TURP vaginal Usual dose 7.5 mg
  • 7.5 mg (1 mL)
Adults · Abdominal abdominal tubal ligation appendectomy Usual dose 12 mg
  • 12 mg (1.6 mL)
Adults · Cesarean section Usual dose 7.5 mg to 10.5 mg
  • 7.5 mg to 10.5 mg (1 mL to 1.4 mL)

See the Full Dosing Instructions on DailyMed →

Exparel

Numbing for pain relief after surgery
Adults Highest dose 266 mg
  • Up to a maximum dose of 266 mg
Children 6 to less than 17 years old Usual dose 4 mg/kg Highest dose 266 mg
Nerve block for pain relief after surgery
Adults · Interscalene brachial plexus Usual dose 133 mg Highest dose 133 mg
Adults · Sciatic popliteal fossa Usual dose 133 mg Highest dose 133 mg
Adults · Adductor canal Usual dose 133 mg Highest dose 133 mg
  • 133 mg (10 mL) admixed with 50 mg (10 mL) 0.5% bupivacaine HCl, for a total volume of 20 mL

See the Full Dosing Instructions on DailyMed →

Xaracoll

Numbing for pain relief after surgery
For adults
Usual dose 300 mg once
  • 300 mg bupivacaine HCl (three 100 mg implants), each cut in half
  • Three halves below mesh site and three halves just below skin closure

Limit Doses above 300 mg not studied

Good to know

Single-dose use

See the Full Dosing Instructions on DailyMed →

Side Effects

Side effects vary by product and procedure. Reported ones include:

Common side effects

  • Nausea
  • Vomiting
  • Constipation (reported with Exparel)
  • Fever (reported with Exparel nerve blocks)
  • Headache (reported with Exparel nerve blocks)
  • Dizziness
  • Low blood pressure

When to get medical help

  • Restlessness, anxiety, confusion, or slurred speech after the injection
  • Numbness or tingling around the mouth or lips, a metallic taste, ringing in the ears, or blurred vision
  • Tremors, twitching, convulsions, or unusual drowsiness
  • Slow or shallow breathing, or loss of consciousness
  • Bluish or gray skin color, which can signal methemoglobinemia (blood that carries less oxygen)
  • Signs of allergic reaction such as breathing trouble or swelling
  • Joint pain, stiffness, or loss of motion in the months after joint infusion of a local anesthetic (chondrolysis, or cartilage damage)

Seizures, breathing trouble, heart rhythm changes, allergic reactions, or bluish skin need urgent attention.

Warnings and Precautions

The biggest risk is toxicity from too much drug reaching the bloodstream, which can cause seizures, cardiac arrest, and death. Early signs include restlessness, tingling around the mouth, metallic taste, ringing in the ears, and dizziness.

  • The 0.75% concentration is not recommended for obstetrical epidural anesthesia.
  • It is contraindicated for intravenous regional anesthesia (Bier block), where cardiac arrest and death were reported.
  • Accidental spinal injection can cause a high spinal block with paralysis and breathing failure.
  • Methemoglobinemia and chondrolysis (joint cartilage damage after joint infusion) can occur.
  • Epinephrine-containing products contain a sulfite that may trigger allergic reactions.

Interactions

These are key interactions to know about:

  • Other local anesthetics: toxic effects add up.
  • MAO inhibitors and tricyclic antidepressants: severe, prolonged high blood pressure with epinephrine products.
  • Ergot-type oxytocics: severe high blood pressure or stroke-type events with epinephrine products.
  • Nonselective beta-blockers: high blood pressure and slow heart rate with epinephrine products.
  • Nitrates, certain antibiotics, antimalarials, anticonvulsants, and acetaminophen: higher methemoglobinemia risk.
  • Potent inhalation anesthetics: serious rhythm problems with epinephrine products.
  • Phenothiazines and butyrophenones: may blunt epinephrine's effect.

Interactions Listed in the FDA-Approved Label

From the Bupivacaine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Other local anesthetics
    What happensThe toxic effects of local anesthetics are additive.
    What to doMonitor for neurologic and cardiovascular effects if coadministration cannot be avoided.
  • Monoamine oxidase inhibitors and tricyclic antidepressants
    What happensBupivacaine with epinephrine may produce severe, prolonged hypertension.
    What to doGenerally avoid concurrent use; if necessary, monitor hemodynamic status carefully.
  • Ergot-type oxytocic drugs
    What happensMay cause severe, persistent hypertension or cerebrovascular accidents.
    What to doAvoid concomitant use.
  • Nonselective beta-adrenergic antagonists
    What happensMay cause severe hypertension and bradycardia.
    What to doGenerally avoid; if necessary, monitor blood pressure and heart rate carefully.
  • Drugs associated with methemoglobinemia (nitrates, nitrites, other local anesthetics, antineoplastics, antibiotics, antimalarials, anticonvulsants)
    What happensIncreased risk of developing methemoglobinemia.
  • Potent inhalation anesthetics
    What happensSerious dose-related cardiac arrhythmias may occur with preparations containing epinephrine.
  • Phenothiazines and butyrophenones
    What happensMay reduce or reverse the pressor effect of epinephrine.
    What to doGenerally avoid concurrent use; if necessary, monitor the patient carefully.
Read the label’s full interactions text

7 DRUG INTERACTIONS • Local Anesthetics: The toxic effects of local anesthetics are additive. Monitor for neurologic and cardiovascular effects when additional local anesthetics are administered. • Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: Administration of Bupivacaine Hydrochloride and Epinephrine Injection to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided. • Ergot-Type Oxytocic Drugs: Concurrent administration of Bupivacaine Hydrochloride and Epinephrine Injection and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents. • Nonselective Beta-Adrenergic Antagonists: Administration of Bupivacaine Hydrochloride and Epinephrine Injection (containing a vasoconstrictor) in patients receiving nonselective beta-adrenergic antagonists may cause severe hypertension and bradycardia. Concurrent use of these agents should generally be avoided. • Drugs Associated with Methemoglobinemia: Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. • Potent Inhalation Anesthetics: Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administration of potent inhalation anesthetics. 7.1 Local Anesthetics The toxic effects of local anesthetics are additive.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use if allergic to bupivacaine or other amide-type local anesthetics.
  • Not for obstetrical paracervical block or Bier block.
  • Pregnancy: crosses the placenta and may affect the mother, fetus, and newborn.
  • Breastfeeding: passes into breast milk, so use only if clearly needed.
  • Children: not recommended under 12 for epinephrine-containing products. Exparel infiltration is approved from age 6.
  • Older adults: more risk of low blood pressure and may need lower doses.
  • Liver or kidney disease: may need dose reduction and closer monitoring.

Overdose

Too much bupivacaine can cause tingling around the mouth, dizziness, confusion, vision changes, and convulsions. Heart effects range from high blood pressure and fast heartbeat to low blood pressure, slow heartbeat, and cardiac arrest. Treatment starts with oxygen and airway support, medicines to stop seizures, and circulatory support. CPR is used if the heart stops.

How Your Body Processes It

How much bupivacaine enters the bloodstream depends on the dose, route, and blood supply at the injection site. After Exparel, bupivacaine was detected in blood for 96 hours after infiltration and up to 168 hours after some nerve blocks. Blood levels with Exparel do not match how well it works locally. Once absorbed, bupivacaine spreads to body tissues. It is broken down by the liver and cleared in part by the kidneys.

Storage

Store bupivacaine liposome injectable suspension vials refrigerated between 2° to 8°C (36° to 46°F). Refrigerate vials. Do not freeze or expose bupivacaine liposome injectable suspension to high temperatures (greater than 40°C or 104°F) for an extended period.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Bupivacaine: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Bupivacaine — the kind of thing our pharmacy team would talk through with you at the counter.

What is bupivacaine used for?

It numbs an area or blocks pain during surgery, dental work, childbirth-related procedures, and diagnostic procedures. Exparel and Xaracoll are specifically used for pain relief after surgery. A spinal form is used for spinal anesthesia.

How is bupivacaine given?

A trained clinician injects it, so you don't take it at home. The injection type depends on your procedure, such as near a nerve, into tissue, or in the epidural or spinal area. They choose the lowest dose that works.

What side effects should I expect?

Nausea, vomiting, constipation, dizziness, headache, and low blood pressure have been reported. Fever and headache were seen with Exparel nerve blocks. Tell your team right away about tingling around the mouth, ringing in the ears, confusion, or trouble breathing.

Is bupivacaine safe during pregnancy or childbirth?

It crosses the placenta and can affect the mother, baby, and newborn. It must not be used for paracervical block, and the 0.75% strength is not recommended for epidural anesthesia in childbirth. Your obstetric team will choose the safest approach.

Does bupivacaine interact with my other medicines?

It can. If your product contains epinephrine, MAO inhibitors, tricyclic antidepressants, ergot drugs, and nonselective beta-blockers can cause dangerous blood pressure changes. Tell your care team everything you take, including acetaminophen, nitrates, and anticonvulsants.

Do liver or kidney problems matter?

Yes. The liver breaks bupivacaine down and the kidneys help remove it, so problems with either can raise the risk of toxicity. Your team may lower your dose and monitor you more closely.

Is bupivacaine available over the counter?

No. Bupivacaine is a prescription medicine: every bupivacaine product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was bupivacaine first available?

The earliest FDA record we hold for bupivacaine is from 1972: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when bupivacaine was first used.

Who makes bupivacaine?

24 companies currently list bupivacaine products in the FDA's NDC Directory, including Hospira, Inc., Eugia US LLC, Hikma Pharmaceuticals USA Inc.. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of bupivacaine?

Bupivacaine is the generic name. Its brand names are Marcaine, Sensorcaine, Xaracoll, Posimir, Sensorcaine MPF and 2 more. Generic versions are listed under the name bupivacaine.

What is the generic name of Marcaine?

The generic name of Marcaine is bupivacaine. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is bupivacaine?

Bupivacaine belongs to the drug class Amide Local Anesthetic, its established pharmacologic class on the FDA label.

Is there a generic version of bupivacaine?

Yes. FDA-approved generic versions of bupivacaine are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does bupivacaine come in?

Bupivacaine is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (around a nerve, behind the eye, into the epidural space, into the fluid around the spinal cord, into the lower spine (caudal), into the tissue at the site): 25 mg/10 mL, 50 mg/10 mL, 75 mg/30 mL, 150 mg/30 mL, 225 mg/30 mL and 250 mg/50 mL. Injection (around a nerve, behind the eye, into the epidural space, into the fluid around the spinal cord, into the lower spine (caudal), into the tissue at the site), amount in each mL: 13.3 mg/mL. A listing does not mean every pharmacy stocks every strength.

How much does bupivacaine cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.05 to $0.09 per mL of the generic injection across 2 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a bupivacaine shortage?

Yes. Bupivacaine is on the FDA's drug shortage list as of Nov 22, 2026. A shortage means some products are hard to get, not that every pharmacy is out. The shortage page lists the affected products and what each company has told the FDA. Read the bupivacaine shortage page

Where can I read the bupivacaine prescribing information (package insert)?

The full FDA-approved prescribing information for bupivacaine, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Pacira Pharmaceuticals, Inc.'s, revised Nov 9, 2026, and links to it on DailyMed.

Is bupivacaine gluten free?

No bupivacaine label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 88 bupivacaine products from 21 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's bupivacaine by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See bupivacaine inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Bupivacaine

Skip the scrolling. Ask in your own words and get an answer from Bupivacaine’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Bupivacaine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Bupivacaine on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Bupivacaine Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Bupivacaine Forms and Strengths (How It Comes)

Bupivacaine comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Bupivacaine inactive ingredients by manufacturer.

Injection

Around a nerve · Behind the eye · Into the epidural space · Into the fluid around the spinal cord · Into the lower spine (caudal) · Into the tissue at the site
Brands Marcaine (1984) Sensorcaine (before 1982) Posimir (2021, discontinued) Sensorcaine MPF Marcaine Spinal
How this form is used
What it may be used for
  • Marcaine and Bupivacaine Hydrochloride injection are used in adults for local or regional anesthesia or analgesia for surgery, dental and oral surgery, diagnostic and therapeutic procedures, and obstetrical procedures.
  • Exparel is used for pain relief after surgery by infiltration (ages 6 and older) or by certain nerve blocks in adults.
Important instructions
  • Bupivacaine Hydrochloride injection is not for intrathecal use.
  • Bupivacaine Hydrochloride multiple-dose vials with preservatives should be avoided for epidural or caudal anesthesia.
  • Bupivacaine Hydrochloride single-dose vial leftovers without preservatives are discarded after first use.
Available strengths 10 strengths
Show 4 more strengths Show fewer strengths
105 FDA-listed product records ⓘ

Bupivacaine on the U.S. Market: Products, Makers and Brands

How Bupivacaine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

24 companies list 104 Bupivacaine product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 1972. Brand names in the directory today include Marcaine, Sensorcaine, Sensorcaine MPF and 2 more; the rest are generics.

1
Dose forms ⓘ
24
Labelers (makers, repackagers, distributors)
7
Brand names ⓘ
104
FDA-listed product records ⓘ
1972
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Powder (26) · Unfinished injection, solution (1) · Unfinished injection, suspension, liposomal (1) · Unfinished liquid (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Hospira, Inc.13%
Eugia US LLC8%
Hikma Pharmaceuticals USA Inc.8%
Onesource Specialty Pharma Limited8%
Xellia Pharmaceuticals USA LLC8%
Henry Schein, Inc.7%
Other makers50%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Bupivacaine Is Used (Medicaid Data)

How many Bupivacaine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

166,102
Medicaid prescriptions filled (Q1–Q4 2025)
$18.7M paid by Medicaid, before rebates

How commonly is Bupivacaine prescribed? Of the 1,682 medications we measure, Bupivacaine ranks #424 by Medicaid prescriptions — more than 75% of them.

Where Bupivacaine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Bupivacaine product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 10 mL / 2.5 mg/mL injection is the most-dispensed Bupivacaine product — about 18% of these Medicaid prescriptions.

10 ML bupivacaine hydrochloride 2.5 MG/ML Injection Most dispensed

30,068 Medicaid prescriptions (Q1–Q4 2025) 18% of Bupivacaine prescriptions shown $2.2M paid by Medicaid, before rebates ≈ $74 per prescription, before rebates

6 of 37 listed NDCs had Medicaid claims. RxNorm 1725078

30 ML bupivacaine hydrochloride 2.5 MG/ML Injection

29,745 Medicaid prescriptions (Q1–Q4 2025) 18% of Bupivacaine prescriptions shown $3.8M paid by Medicaid, before rebates ≈ $127 per prescription, before rebates

9 of 28 listed NDCs had Medicaid claims. RxNorm 1725082

30 ML bupivacaine hydrochloride 5 MG/ML Injection

24,729 Medicaid prescriptions (Q1–Q4 2025) 15% of Bupivacaine prescriptions shown $2.7M paid by Medicaid, before rebates ≈ $110 per prescription, before rebates

8 of 28 listed NDCs had Medicaid claims. RxNorm 1724884

10 ML bupivacaine hydrochloride 5 MG/ML Injection

21,842 Medicaid prescriptions (Q1–Q4 2025) 13% of Bupivacaine prescriptions shown $1.3M paid by Medicaid, before rebates ≈ $62 per prescription, before rebates

7 of 40 listed NDCs had Medicaid claims. RxNorm 1724880

bupivacaine hydrochloride 5 MG/ML Injectable Solution

14,747 Medicaid prescriptions (Q1–Q4 2025) 9% of Bupivacaine prescriptions shown $363,354 paid by Medicaid, before rebates ≈ $25 per prescription, before rebates

10 of 45 listed NDCs had Medicaid claims. RxNorm 1012404

bupivacaine hydrochloride 2.5 MG/ML Injectable Solution

11,231 Medicaid prescriptions (Q1–Q4 2025) 7% of Bupivacaine prescriptions shown $403,950 paid by Medicaid, before rebates ≈ $36 per prescription, before rebates

7 of 34 listed NDCs had Medicaid claims. RxNorm 1012396

20 ML bupivacaine liposome 13.3 MG/ML Injection

8,835 Medicaid prescriptions (Q1–Q4 2025) 5% of Bupivacaine prescriptions shown $4.1M paid by Medicaid, before rebates ≈ $460 per prescription, before rebates

2 of 4 listed NDCs had Medicaid claims. RxNorm 1191508

10 ML bupivacaine liposome 13.3 MG/ML Injection

4,612 Medicaid prescriptions (Q1–Q4 2025) 3% of Bupivacaine prescriptions shown $1.9M paid by Medicaid, before rebates ≈ $417 per prescription, before rebates

2 of 4 listed NDCs had Medicaid claims. RxNorm 1745061

10 ML bupivacaine hydrochloride 7.5 MG/ML Injection

2,275 Medicaid prescriptions (Q1–Q4 2025) 1% of Bupivacaine prescriptions shown $64,133 paid by Medicaid, before rebates ≈ $28 per prescription, before rebates

6 of 19 listed NDCs had Medicaid claims. RxNorm 1724787

2 ML bupivacaine hydrochloride 7.5 MG/ML Injection

941 Medicaid prescriptions (Q1–Q4 2025) <1% of Bupivacaine prescriptions shown $224,637 paid by Medicaid, before rebates ≈ $239 per prescription, before rebates

2 of 16 listed NDCs had Medicaid claims. RxNorm 1724784

30 ML bupivacaine hydrochloride 7.5 MG/ML Injection

685 Medicaid prescriptions (Q1–Q4 2025) <1% of Bupivacaine prescriptions shown $84,259 paid by Medicaid, before rebates ≈ $123 per prescription, before rebates

3 of 23 listed NDCs had Medicaid claims. RxNorm 1724786

Other Bupivacaine products: packs and listings not matched to one strength and form

16,392 Medicaid prescriptions (Q1–Q4 2025) 10% of Bupivacaine prescriptions shown $1.5M paid by Medicaid, before rebates ≈ $93 per prescription, before rebates

19 of 99 listed NDCs had Medicaid claims.

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 81 of the 377 listed Bupivacaine NDCs had Medicaid claims.

Compare Bupivacaine Products

A representative set of FDA-listed product records for Bupivacaine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 104 of 104 products — FDA National Drug Code Directory. See every product, package size and price: browse all 104 Bupivacaine NDCs →

Bupivacaine Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list 2 Bupivacaine recalls since July 2021, covering 3 product listings. One of them is still ongoing and is listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Ongoing Class II Apr 2, 2026 · Huons Co., Ltd.
Lack of Assurance of Sterility
  • Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only, Manufactured by: Houns Co., Ltd, 100, Bio valley, Je-cheor-Si, Chungcheongbuk-dc, Korea, ND… Lots: All lots within expiry FDA record D-0530-2026 →
Class II Apr 13, 2022 · Terminated · Mckesson Medical-Surgical Inc. Corporate Office
cGMP deviations: Temperature abuse
  • Bupivacaine Hydrochloride, USP 0.5% (5mg/mL), 25 vials x 50 mL per box, Rx only, MFG: Pfizer, NDC 0409-1163-01 Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that i… FDA record D-1095-2022 →
  • Bupivacaine HCl Injection, single dose vial, Preservative Free 0.5%, 10mL (25/ct), Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-169-10 Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that i… FDA record D-0998-2022 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Bupivacaine in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
3
Strengths
17
Forms in current FDA listings
2 of 3
In current FDA listings No current FDA listing
Ingredient (IN) Bupivacaine RxCUI 1815
  1. Dose form (SCDF) Drug Implant RxCUI 2395790
    No current FDA listing
    Its strength (SCD)
    • 100 mg hydrochloride RxCUI 2395791
  2. Dose form (SCDF) Injectable Solution RxCUI 371160
    In current FDA listings
    Its 3 strengths (SCD)
    • 1.05 mg/mL hydrochloride RxCUI 1012431
    • 2.5 mg/mL hydrochloride RxCUI 1012396
    • 5 mg/mL hydrochloride RxCUI 1012404
  3. Dose form (SCDF) Injection RxCUI 1724783
    In current FDA listings
    Its 13 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Bupivacaine Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Bupivacaine: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Nov 2024.

Strength

For the generic 5 mg/mL injection, pharmacies paid an average of $0.086 per mL as of Nov 18, 2026, up 4.9% from $0.082 a year earlier.

What pharmacies pay now
$0.086
per mL, as of Nov 18, 2026
Last 4 weeks
No change
from $0.086 on Oct 21, 2026
Last 12 months
Up 4.9%
from $0.082 on Nov 19, 2025
Lowest and highest since Nov 2024
$0.070 to $0.086
per mL

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 5 mg/mL injection: the average pharmacy price per mL, the last survey of each month
MonthPharmacy price
Nov 2026$0.086
Oct 2026$0.086
Sep 2026$0.086
Aug 2026$0.086
Jul 2026$0.086
Jun 2026$0.086
May 2026$0.086
Apr 2026$0.086
Mar 2026$0.083
Feb 2026$0.083
Jan 2026$0.082
Dec 2025$0.078
Nov 2025$0.082
Oct 2025$0.081
Sep 2025$0.083
Aug 2025$0.078
Jul 2025$0.075
Jun 2025$0.077
May 2025$0.072
Apr 2025$0.070
Mar 2025$0.070
Feb 2025$0.073
Jan 2025$0.076
Dec 2024$0.073
Nov 2024$0.073
FormStrengthVersion What pharmacies pay
Injection · Perineural 2.5 mg/mL Generic $0.048 per mL NDC details & price history
Injection · Infiltration, Perineural 5 mg/mL Generic $0.086 per mL NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Bupivacaine Brand Names

Bupivacaine has 7 brand names on record: Marcaine, Sensorcaine, Xaracoll, Posimir and others. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Marcaine 1984 Sensorcaine before 1982 Xaracoll 2020, discontinued Posimir 2021, discontinued Sensorcaine MPF Bupivacaine Spinal Marcaine Spinal

Who Makes Bupivacaine: Manufacturers and Labelers

24 companies list Bupivacaine products with the FDA. By number of product records, the largest are Hospira, Inc., Eugia US LLC, Hikma Pharmaceuticals USA Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Hospira, Inc. 13 Eugia US LLC 8 Hikma Pharmaceuticals USA Inc. 8 Onesource Specialty Pharma Limited 8 Xellia Pharmaceuticals USA LLC 8 Henry Schein, Inc. 7 Asclemed USA, Inc. 6 NorthStar RxLLC 6 Anthea Pharma Private Limited 5 Fresenius Kabi USA, LLC 5 HF Acquisition Co LLC, DBA HealthFirst 5 Camber Pharmaceuticals, Inc. 3 Medical Purchasing Solutions, LLC 3 Sportpharm LLC 3 Fosun Pharma USA Inc. 2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. 2 Meitheal Pharmaceuticals Inc 2 Pacira Pharmaceuticals, Inc. 2 ProPharma Distribution 2 Somerset Therapeutics, LLC 2 A-S Medication Solutions 1 Brookfield Pharmaceuticals, LLC. 1 Cardinal Health 107, LLC 1 Huons Co., Ltd. 1

Sources for This Bupivacaine Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Nov 9, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Bupivacaine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 60 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
60
Finished products in the current FDA directory
104
Companies listing them (makers, repackagers, distributors)
24
FDA labeler codes behind them ⓘ
25
Linked representative label ⓘ
Pacira Pharmaceuticals, Inc.
Linked label effective
Nov 9, 2026
Composite sections available
23
Linked SPL Set ID
bb5a9e59-0f51-11df-8a39-0800200c9a66
Linked SPL Document ID
3f9501c4-d960-4cb4-b50f-909aede00817
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Pacira Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →